Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Combining Nivolumab and Ipilimumab With Infliximab or Certolizumab in Patients With Advanced Melanoma: First Results of a Phase 1b Clinical TrialClin. Cancer Res 2020 Dec 03;[EPub Ahead of Print], A Montfort, T Filleron, M Virazels, C Dufau, J Milhès, C Pages, P Olivier, M Ayyoub, M Mounier, A Lusque, S Brayer, JP Delord, N Andrieu-Abadie, T Levade, C Colacios, B Ségui, N Meyer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.